Matti J Valimaki

Summary

Affiliation: University of Helsinki
Country: Finland

Publications

  1. ncbi request reprint Effects of risedronate 5 mg/d on bone mineral density and bone turnover markers in late-postmenopausal women with osteopenia: a multinational, 24-month, randomized, double-blind, placebo-controlled, parallel-group, phase III trial
    Matti J Valimaki
    Division of Endocrinology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland
    Clin Ther 29:1937-49. 2007
  2. ncbi request reprint Risk factors for clinical stress fractures in male military recruits: a prospective cohort study
    Ville Valtteri Välimäki
    Department of Medicine, Division of Endocrinology, Helsinki University Central Hospital, FIN 00290 Helsinki, Finland
    Bone 37:267-73. 2005
  3. ncbi request reprint Vitamin D status as a determinant of peak bone mass in young Finnish men
    Ville Valtteri Välimäki
    Division of Endocrinology, Department of Medicine, Helsinki University Central Hospital, FIN 00290 Helsinki, Finland
    J Clin Endocrinol Metab 89:76-80. 2004
  4. ncbi request reprint Effects of alendronate and hormone replacement therapy, alone and in combination, on bone mass and markers of bone turnover in elderly women with osteoporosis
    Sirpa Eviö
    Department of Obstetrics and Gynecology, Helsinki University Central Hospital, FIN 00029 HUS Helsinki, Finland
    J Clin Endocrinol Metab 89:626-31. 2004
  5. doi request reprint The same annual dose of 292000 IU of vitamin D (cholecalciferol) on either daily or four monthly basis for elderly women: 1-year comparative study of the effects on serum 25(OH)D concentrations and renal function
    Tuula Pekkarinen
    Department of Internal Medicine, Peijas Hospital, Helsinki University Central Hospital, Vantaa, Finland
    Clin Endocrinol (Oxf) 72:455-61. 2010
  6. ncbi request reprint The relation of the XbaI and PvuII polymorphisms of the estrogen receptor gene and the CAG repeat polymorphism of the androgen receptor gene to peak bone mass and bone turnover rate among young healthy men
    Ville Valtteri Välimäki
    Division of Endocrinology, Helsinki University Central Hospital, 00290, Helsinki, Finland
    Osteoporos Int 16:1633-40. 2005
  7. doi request reprint Post-ablative serum thyroglobulin is an independent predictor of recurrence in low-risk differentiated thyroid carcinoma: a 16-year follow-up study
    Hanna Pelttari
    Division of Endocrinology, Department of Medicine, Helsinki University Central Hospital, PO Box 340, FI 00290 Helsinki, Finland
    Eur J Endocrinol 163:757-63. 2010
  8. ncbi request reprint The A1330V polymorphism of the low-density lipoprotein receptor-related protein 5 gene (LRP5) associates with low peak bone mass in young healthy men
    Anne Saarinen
    Folkhälsan Institute of Genetics and Department of Medical Genetics, University of Helsinki, Helsinki, Finland
    Bone 40:1006-12. 2007
  9. doi request reprint Long-term outcome of 495 TNM stage I or II patients with differentiated thyroid carcinoma followed up with neck ultrasonography and thyroglobulin measurements on T4 treatment
    Hanna Pelttari
    Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland
    Clin Endocrinol (Oxf) 69:323-31. 2008
  10. doi request reprint Serum 25(OH)D3 vitamin status of elderly Finnish women is suboptimal even after summer sunshine but is not associated with bone density or turnover
    Tuula Pekkarinen
    Department of Internal Medicine, Peijas Hospital, Helsinki University Central Hospital, Helsinki, Finland
    Eur J Endocrinol 162:183-9. 2010

Collaborators

Detail Information

Publications24

  1. ncbi request reprint Effects of risedronate 5 mg/d on bone mineral density and bone turnover markers in late-postmenopausal women with osteopenia: a multinational, 24-month, randomized, double-blind, placebo-controlled, parallel-group, phase III trial
    Matti J Valimaki
    Division of Endocrinology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland
    Clin Ther 29:1937-49. 2007
    ..Although the effects of risedronate in preventing frac- tures has been established, its effects in maintaining or increasing BMD in osteopenia have not...
  2. ncbi request reprint Risk factors for clinical stress fractures in male military recruits: a prospective cohort study
    Ville Valtteri Välimäki
    Department of Medicine, Division of Endocrinology, Helsinki University Central Hospital, FIN 00290 Helsinki, Finland
    Bone 37:267-73. 2005
    ..Given the poor vitamin D status of young Finnish men, intervention studies of vitamin D supplementation to lower serum PTH levels and to possibly reduce the incidence of stress fractures are warranted...
  3. ncbi request reprint Vitamin D status as a determinant of peak bone mass in young Finnish men
    Ville Valtteri Välimäki
    Division of Endocrinology, Department of Medicine, Helsinki University Central Hospital, FIN 00290 Helsinki, Finland
    J Clin Endocrinol Metab 89:76-80. 2004
    ....
  4. ncbi request reprint Effects of alendronate and hormone replacement therapy, alone and in combination, on bone mass and markers of bone turnover in elderly women with osteoporosis
    Sirpa Eviö
    Department of Obstetrics and Gynecology, Helsinki University Central Hospital, FIN 00029 HUS Helsinki, Finland
    J Clin Endocrinol Metab 89:626-31. 2004
    ..In terms of BMD changes, the single treatments were equally effective, but the reductions in bone markers were less with HRT than with alendronate...
  5. doi request reprint The same annual dose of 292000 IU of vitamin D (cholecalciferol) on either daily or four monthly basis for elderly women: 1-year comparative study of the effects on serum 25(OH)D concentrations and renal function
    Tuula Pekkarinen
    Department of Internal Medicine, Peijas Hospital, Helsinki University Central Hospital, Vantaa, Finland
    Clin Endocrinol (Oxf) 72:455-61. 2010
    ..We compared the efficacy and safety of two oral dosages (800 IU daily or 97333 IU four monthly) of vitamin D(3) resulting in the equal annual dose of 292000 IU...
  6. ncbi request reprint The relation of the XbaI and PvuII polymorphisms of the estrogen receptor gene and the CAG repeat polymorphism of the androgen receptor gene to peak bone mass and bone turnover rate among young healthy men
    Ville Valtteri Välimäki
    Division of Endocrinology, Helsinki University Central Hospital, 00290, Helsinki, Finland
    Osteoporos Int 16:1633-40. 2005
    ..Our study does not support the view that the XbaI and PvuII polymorphisms of the ER gene and the CAG polymorphism of the AR gene would have a substantial impact on the development of peak bone mass in young Finnish men...
  7. doi request reprint Post-ablative serum thyroglobulin is an independent predictor of recurrence in low-risk differentiated thyroid carcinoma: a 16-year follow-up study
    Hanna Pelttari
    Division of Endocrinology, Department of Medicine, Helsinki University Central Hospital, PO Box 340, FI 00290 Helsinki, Finland
    Eur J Endocrinol 163:757-63. 2010
    ..To study whether post-surgical and/or post-ablative thyroglobulin (Tg) concentrations may serve as independent predictors of disease recurrence in patients treated for TNM stage I or II well-differentiated thyroid carcinoma (WDTC)...
  8. ncbi request reprint The A1330V polymorphism of the low-density lipoprotein receptor-related protein 5 gene (LRP5) associates with low peak bone mass in young healthy men
    Anne Saarinen
    Folkhälsan Institute of Genetics and Department of Medical Genetics, University of Helsinki, Helsinki, Finland
    Bone 40:1006-12. 2007
    ..Whether this is due to influence on bone mass acquisition or on bone loss thereafter has not been established...
  9. doi request reprint Long-term outcome of 495 TNM stage I or II patients with differentiated thyroid carcinoma followed up with neck ultrasonography and thyroglobulin measurements on T4 treatment
    Hanna Pelttari
    Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland
    Clin Endocrinol (Oxf) 69:323-31. 2008
    ..We evaluated the safety and efficacy of a surveillance paradigm comprising yearly T(4)-suppressed Tg measurements and neck US every second year, with an increase in Tg to a detectable level being a prompt indication for DxWBS...
  10. doi request reprint Serum 25(OH)D3 vitamin status of elderly Finnish women is suboptimal even after summer sunshine but is not associated with bone density or turnover
    Tuula Pekkarinen
    Department of Internal Medicine, Peijas Hospital, Helsinki University Central Hospital, Helsinki, Finland
    Eur J Endocrinol 162:183-9. 2010
    ..We evaluated vitamin D status of elderly Finnish women in light of these definitions, its relationship to bone mineral density (BMD) and turnover, and improvement by summer sunshine...
  11. ncbi request reprint Prevention of bone loss after allogeneic stem cell transplantation by calcium, vitamin D, and sex hormone replacement with or without pamidronate
    Kristiina Kananen
    Division of Endocrinology, Department of Medicine, Helsinki University Central Hospital, FIN 00290 Helsinki, Finland
    J Clin Endocrinol Metab 90:3877-85. 2005
    ..In controlled studies, bisphosphonates have been used to prevent bone loss after solid organ transplantations but not in conjunction with stem cell transplantation (SCT)...
  12. doi request reprint BRAF V600E mutation does not predict recurrence after long-term follow-up in TNM stage I or II papillary thyroid carcinoma patients
    Hanna Pelttari
    Division of Endocrinology, Department of Medicine, Helsinki University Central Hospital, Finland
    APMIS 120:380-6. 2012
    ..2 cm, 21% vs 35% and 6% vs 12%, respectively, all p = NS). Taken together, BRAF V600E is common in Finnish patients with low-risk PTC but does not predict recurrence after long-term follow-up after initial treatment with TTE and RRA...
  13. ncbi request reprint Serum tartrate-resistant acid phosphatase 5b or amino-terminal propeptide of type I procollagen for monitoring bisphosphonate therapy in postmenopausal osteoporosis?
    Matti J Valimaki
    Division of Endocrinology, Department of Medicine, Helsinki University Central Hospital, Finland
    Clin Chem 51:2382-5. 2005
  14. ncbi request reprint Serum estradiol, testosterone, and sex hormone-binding globulin as regulators of peak bone mass and bone turnover rate in young Finnish men
    Ville Valtteri Välimäki
    Division of Endocrinology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland
    J Clin Endocrinol Metab 89:3785-9. 2004
    ..Moreover, serum SHBG appeared to be an independent positive predictor of bone turnover rate, which also positively associated with serum 25-hydroxyvitamin-D levels...
  15. doi request reprint Comparison of two growth hormone stimulation tests and their cut-off limits in healthy adults at an outpatient clinic
    Helene M Markkanen
    Department of Clinical Chemistry, Helsinki University Central Hospital, FI 00029 HUS, Finland
    Growth Horm IGF Res 23:165-9. 2013
    ....
  16. doi request reprint Health-related quality of life in long-term follow-up of patients with cured TNM Stage I or II differentiated thyroid carcinoma
    Hanna Pelttari
    Division of Endocrinology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland
    Clin Endocrinol (Oxf) 70:493-7. 2009
    ..The purpose of this study was to assess the impact of cured low-risk differentiated thyroid carcinoma (DTC) on health-related quality of life (HRQoL) after long-term follow-up...
  17. doi request reprint Serum TSH reference interval in healthy Finnish adults using the Abbott Architect 2000i Analyzer
    Camilla Schalin-Jantti
    Division of Endocrinology, Department of Medicine, Helsinki University Central Hospital, Finland
    Scand J Clin Lab Invest 71:344-9. 2011
    ..The objective was to redefine the TSH reference interval in the adult Finnish population. The current reference interval for the widely used Abbott Architect method in Finland is 0.4-4.0 mU/L...
  18. ncbi request reprint The effect of hormone therapy on the health-related quality of life in elderly women
    Sirpa Eviö
    Department of Obstetrics and Gynecology, Helsinki University Central Hospital, PB 140, 00029 Helsinki, Finland
    Maturitas 56:122-8. 2007
    ..The purpose of this study was to compare the health-related quality of life (HRQoL) of elderly users and non-users of hormone therapy (HT)...
  19. doi request reprint The novel WHO 2010 classification for gastrointestinal neuroendocrine tumours correlates well with the metastatic potential of rectal neuroendocrine tumours
    Juha Jernman
    Department of Pathology, Haartman Institute and HUSLAB, Helsinki University Central Hospital, Haarmaninkatu 3, Helsinki, Finland
    Neuroendocrinology 95:317-24. 2012
    ..Of 11 G2 tumours, 9 had shown distant metastases. The only G3 neuroendocrine carcinoma that occurred had been disseminated at initial presentation...
  20. ncbi request reprint Effect of sex and assay method on serum concentrations of growth hormone in patients with acromegaly and in healthy controls
    Helene Markkanen
    Department of Clinical Chemistry, Helsinki University Hospital, Helsinki, Finland
    Clin Chem 52:468-73. 2006
    ..A nadir value <1 microg/L is commonly used to define a normal response, but some authors suggest lower cutoff values...
  21. doi request reprint Parathyroid hormone treatment improves pain and fracture healing in adult hypophosphatasia
    Camilla Schalin-Jantti
    Division of Endocrinology, Department of Medicine, Helsinki University Central Hospital, P O Box 340, FI 00290 Helsinki, Finland
    J Clin Endocrinol Metab 95:5174-9. 2010
    ..Increased S-ALP and fracture repair were reported in two patients treated with teriparatide, PTH 1-34. The effects of full-length PTH 1-84 have not been studied...
  22. ncbi request reprint The effects of transdermal estrogen therapy on bone mass and turnover in early postmenopausal smokers: a prospective, controlled study
    Matti J Valimaki
    Division of Endocrinology, Department of Medicine, Helsinki University Central Hospital, FIN 00290 Helsinki, Finland
    Am J Obstet Gynecol 189:1213-20. 2003
    ..The purpose of this study was to investigate whether smoking reduces the effects of transdermal estrogen replacement therapy on bone...
  23. doi request reprint Planar scintigraphy with 123I/99mTc-sestamibi, 99mTc-sestamibi SPECT/CT, 11C-methionine PET/CT, or selective venous sampling before reoperation of primary hyperparathyroidism?
    Camilla Schalin-Jantti
    Division of Endocrinology, Department of Medicine, University of Helsinki, Helsinki, Finland
    J Nucl Med 54:739-47. 2013
    ....
  24. ncbi request reprint Manifestation, management and molecular analysis of candidate genes in two rare cases of thyrotoxic hypokalemic periodic paralysis
    Camilla Schalin-Jantti
    Division of Endocrinology, Department of Medicine, University of Helsinki, Finland
    Horm Res 63:139-44. 2005
    ..Ion channel gene mutations may underlie these diseases. We describe the first pediatric and a rare adult Caucasian case of THypoKPP in Finland...